Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

Analysis of cell-free DNA using next-generation sequencing (NGS) is a powerful tool for the detection/monitoring of alterations present in circulating tumor DNA (ctDNA). Plasma extracted from 171 patients with a variety of cancers was analyzed for ctDNA (54 genes and copy number variants (CNVs) in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaederle, Maria, Husain, Hatim, Fanta, Paul T., Piccioni, David E., Kesari, Santosh, Schwab, Richard B., Banks, Kimberly C., Lanman, Richard B., Talasaz, AmirAli, Parker, Barbara A., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891078/
https://www.ncbi.nlm.nih.gov/pubmed/26848768
http://dx.doi.org/10.18632/oncotarget.7110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891078/
https://www.ncbi.nlm.nih.gov/pubmed/26848768
http://dx.doi.org/10.18632/oncotarget.7110

Ejemplares similares